
Programme 2016
Prenez note que la conférence aura lieu essentiellement en anglais
7:45-8:30
Inscription
8:30 - 8:45
Mots d'ouverture
Perry Niro, President, Pharmed Canada
8:45 - 9:30
Global life sciences sector outlook
2016 Deals, M&A and partnering forecast for 2017
-
Douglas Loe, Analyst, Healthcare & Biotech, Echelon Wealth Partners
9:30-10:15
Partnering across the borders with Pharma Ventures
-
Jennifer Hamilton, Senior Director, New Ventures (Canada), Johnson & Johnson Innovation
-
Steven Xanthoudakis, Director, Business Development & Licensing at Merck
-
Amyn Sayani, Ph.D., Director, R&D Alliances, GlaxoSmithKline Canada
10:15 - 10:35
Pause
10:35 - 11:30
Cross-border VC Deals: Joining the Dots
Modéré par Stephen Nagler, Executive Director, MedPro Investors, New York
-
Alex Zisson, Managing Director, HIG Capital, New York
-
Caroline Stout, Investor, EcoR1 Capital, San Francisco
-
Josh Richardson, Principal, Longitude Capital, Menlo Park, California
11:30 - 12:15
CEO Panel: Show me the money, dealing with VCs!
Modéré par Didier Leconte, Senior Director, Investments - Life Sciences, FSFTQ
-
Panel of 3 CEO who accomplished major fundraising this year !
Midi Conférence
Conférencier à confirmer
13:45 - 14:30
Life Sciences EY Report 2016
Beyond borders, Reaching new heights
-
Sylvain Boucher, CPA, Partner, EY Canada
14:30 - 15:15
How to commercialize Digital Health and Medical Technologies
Modéré par Jean-Francois Pariseau, Partner, Healthcare Fund, BDC Venture Capital
-
Ajit Singh, Partner, Artiman Ventures , Palo Alto
-
Brent Norton, Venture Partner, Lumira Capital, Toronto
15:15 - 15:30
Pause
15:45 - 16:45
Healthcare: Opportunities & Challenges for Medtech
Modéré par Yvan Beaudoin, Executive Director, CTS Santé Fund
Panel of entrepreneurs and investors
16:45
Conclusions et Cocktail